Carboplatin/paclitaxel

Carboplatin/paclitaxel Reactions 1704, p87 - 2 Jun 2018 Worsening of pleural effusion and increasing respiratory distress: case report A 44-year-old man developed worsening of pleural effusion and increasing respiratory distress during treatment with carboplatin and paclitaxel [dosages and routes not stated]. The man was diagnosed with salivary gland secretory carcinoma and underwent a local excision. He was also found to have ETV6-NTRK3 fusion, CDKN2A/B loss and APC mutation. Two months post-operation, he presented with shortness of breath and increasing cough. He was found to have mediastinal lymphadenopathy, multiple pleural-based nodules and a large pleural effusion, which indicated metastatic disease. Adenocarcinoma was confirmed. He received one cycle of combined chemotherapy with paclitaxel and carboplatin. However, he developed complications of worsening pleural effusions and increasing respiratory distress [times to reactions onsets not stated]. One month after the start of therapy, there was progression in the size and number of pleural metastases. Therefore, the man was initiated on crizotinib during hospitalisation, which resulted in improvement in his respiratory symptoms and tolerance of exertion over the following weeks. After 10 weeks of crizotinib therapy, he returned to the hospital for worsening respiratory distress and was noted to have a progression of disease in the thorax. Thereafter, he died [exact cause of death not stated]. Author comment: "Carboplatin and paclitaxel exacerbated the symptoms". "The patient received one cycle of combined chemotherapy with carboplatin and paclitaxel, which was complicated by worsening pleural effusions, increasing respiratory distress. . ." Cipriani NA, et al. Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib. International Journal of Surgical Pathology 25: 613-618, No. 7, Oct 2017. Available from: URL: http://doi.org/10.1177/1066896917709350 - USA 803322786 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Carboplatin/paclitaxel

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/carboplatin-paclitaxel-hfgnrzI8Vg
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46730-7
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p87 - 2 Jun 2018 Worsening of pleural effusion and increasing respiratory distress: case report A 44-year-old man developed worsening of pleural effusion and increasing respiratory distress during treatment with carboplatin and paclitaxel [dosages and routes not stated]. The man was diagnosed with salivary gland secretory carcinoma and underwent a local excision. He was also found to have ETV6-NTRK3 fusion, CDKN2A/B loss and APC mutation. Two months post-operation, he presented with shortness of breath and increasing cough. He was found to have mediastinal lymphadenopathy, multiple pleural-based nodules and a large pleural effusion, which indicated metastatic disease. Adenocarcinoma was confirmed. He received one cycle of combined chemotherapy with paclitaxel and carboplatin. However, he developed complications of worsening pleural effusions and increasing respiratory distress [times to reactions onsets not stated]. One month after the start of therapy, there was progression in the size and number of pleural metastases. Therefore, the man was initiated on crizotinib during hospitalisation, which resulted in improvement in his respiratory symptoms and tolerance of exertion over the following weeks. After 10 weeks of crizotinib therapy, he returned to the hospital for worsening respiratory distress and was noted to have a progression of disease in the thorax. Thereafter, he died [exact cause of death not stated]. Author comment: "Carboplatin and paclitaxel exacerbated the symptoms". "The patient received one cycle of combined chemotherapy with carboplatin and paclitaxel, which was complicated by worsening pleural effusions, increasing respiratory distress. . ." Cipriani NA, et al. Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib. International Journal of Surgical Pathology 25: 613-618, No. 7, Oct 2017. Available from: URL: http://doi.org/10.1177/1066896917709350 - USA 803322786 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off